ICYMI: Recruitment Has Begun For a Phase I Clinical Trial of A Drug Designed to Treat Parkinsonian Diseases
<a href="https://pixabay.com/users/qimono/">qimono</a> / Pixabay

ICYMI: Recruitment Has Begun For a Phase I Clinical Trial of A Drug Designed to Treat Parkinsonian Diseases

Prana Biotechnology has announced that it has begun recruiting healthy volunteers for its Phase I clinical trial of the experimental drug PBT434. The drug is thought to affect processes linked…

Continue Reading
Close Menu